G-BA meetings
Ever wondered if patients influence the G-BA decision-making?
Category: News and updates
Orphan drug re-assessments
What happens when the sales for an orphan drug exceed €50 mn in a 12 months period?
G-BA publishes an overview of all method assessments
For anyone working on German market access and / or medical devices, these G-BA news might be interesting. The link to the